Involving adult inpatients, family, partners and/or carers in measuring and monitoring patient safety in acute care hospitals: Protocol for an umbrella review Authors: Róisín O'Malley, Caoimhe Madden, Paul O'Connor, Warren Reilly, Elaine Toomey, Tom Reader, John Fitzsimons, Ronan Mahon, Sinéad Lydon, Leila Keshtkar, Ramkrishna Mondal, Ramkrishna Mondal, Róisín O'Malley, Leila Keshtkar, Róisín O'Malley Published: 2026 ABSTRACT BackgroundInternationally, there is a growing emphasis on the importance and value of the patient’s “voice”, and the unique insights patients and their families have into healthcare system functioning. However, despite international policy shifts toward empowering patients to support patient safety, there remains a lack of knowledge regarding the full range of existing approaches for facilitating patient involvement in measuring and monitoring patient safety (MMS) in the hospital. This umbrella review will aim to identify existing approaches to involving adult inpatients (or family/partners/carers communicating on their behalf ) in MMS in hospital settings, along with evidence supporting their use.MethodsThe current review will adhere to the Joanna Briggs Institute guidance for umbrella reviews and the Preferred Reporting Items for Overviews of Reviews (PRIOR) checklist. Systematic searches will be conducted across five electronic databases (MEDLINE, CINAHL, PsycINFO, Scopus, and Academic Search Complete) to identify existing reviews that consider patient-involvement in MMS in hospital settings. Data will be extracted on the characteristics of approaches identified (e.g., surveys, interviews, incident reporting) any evidence of their feasibility, contextual appropriateness and psychometric properties, along with any reported barriers or facilitators relating to their implementation. Methodological quality will be appraised using the CASP checklist, and certainty of evidence will be assessed via a hybrid GRADE and GRADE-CERQual approach.ConclusionsThis umbrella review will deliver a comprehensive profile of each different approach to involving patients, families and carers in MMS in hospital settings. By evaluating the psychometric evidence and practical feasibility (APEASE criteria and reported barriers and facilitators to use) of these approaches, the findings will support the ascertainment of best practice to involving patients in MMS in hospital settings, ultimately reflecting the important shift in the historical framing of patients as passive recipients of care to active partners in safe and effective care delivery. Introduction Historically, efforts to improve the safety of care have focused on the healthcare professional. 1 Healthcare professionals are, for example, encouraged to report adverse events or concerns using incident reporting systems, involved in completing chart audits to identify errors, and complete surveys which assess safety. 2 Meanwhile, the patient ‘voice’, and the potential for patients to provide data to support patient safety improvement in hospitals has been considered less often. 1, 3 Current practices often position the patient as passive, merely experiencing safety incidents and healthcare delivery, and fail to recognise the active role patients can play in ensuring safe care. 4 However, recent decades have seen a significant shift in the research literature and healthcare policy internationally toward empowering patients to act as active partners in both their own care and efforts to improve the delivery of care. 1 Patients and their families have substantial insight into healthcare system functioning, observing all healthcare interactions. 3 They have privileged access to information on continuity of care, communication failures, and respect issues. 5 Further, patients and families experience important elements of healthcare that are not observable to healthcare workers, such as admission processes and post-discharge care. 5 Patients can also provide preventative information on near misses or behaviours they perceive as concerning (e.g., poor infection control), and are well-placed to capture the nuanced harms associated with adverse events, including psychological and financial harm. 3 Accordingly, a Patient Involvement movement has emerged and seeks to position patients and the public at the centre of healthcare planning and delivery. 6 In practice, this involves, for example, meaningfully engaging patients as equal partners in making informed choices about their treatments, clinical plans, and care preferences. 7 Beyond supporting the delivery of their care and management of their health, patients are also now seen as key stakeholders in the management of patient safety. 1 A variety of ways in which patients can contribute to supporting patient safety have been identified. 4 For example, patients can actively safeguard their care by self-monitoring high-risk medications like anticoagulants, prompting healthcare workers to follow hand-hygiene protocols, actively engaging in medication reconciliation to prevent administration errors, alerting clinical teams to concerning symptoms, tracking post-discharge symptoms to prevent hospital readmissions, and participating in hospital safety committees to help redesign systems and processes. 8 Another mechanism through which patients can support patient safety is by participating in safety data collection. Consistent data collection and analysis is required to identify areas where intervention is required to improve safety. 2 Despite the valuable insights that patients, their families and carers, may have in relation to the quality and safety of care delivered, they are not routinely provided with such opportunities to provide safety data in many countries. 3 To address this need, a range of methods have been developed that proactively gather data on patients’ perceptions of safety conditions, risks or hazards, or safety behaviours while in the hospital. For example, patients can complete surveys to assess the safety of their care, 9 bedside interviews to discuss safety concerns, 10 or review their clinical notes for errors. 11 There are also reactive methods which involve patients in gathering data following adverse events. These include the analysis of complaints and patient incident reporting tools. 1, 10 Where opportunities to provide safety data are available, research suggests that patient participation is high. 12 This importance of providing, and embedding, opportunities for patient involvement in safety measurement has been emphasised in a recent Lancet editorial. 13 ‘Engaging patients and families as partners in safety care’ has been cited as a guiding principle of the WHO’s Global Patient Safety Action Plan 2021–2030. 14 In the US, implementation of a patient reporting tool has been identified as a national goal. 11 In the UK, the National Patient Safety Agency includes patient reports of safety incidents in its National Reporting and Learning System. 1 In Ireland, the first strategic commitment within the Health Service Executive’s Patient Safety Strategy 15 is “Empowering and Engaging Patients to Improve Patient Safety”, and developing scalable mechanisms for patient input and formalising the role of families and carers in the safety process is urged. The importance of the patient’s ‘voice’ to supporting and improving patient safety has also been emphasised by many patient organisations and networks in the UK, 16 the US, 17 and internationally. 18– 20 Although the importance of involving patients in measuring and monitoring patient safety (MMS) is therefore well-recognised and supported, there remains a lack of knowledge regarding the full range of approaches that exist for facilitating patient involvement in MMS, as well as the specific contextual factors, including practicability and equitability, that should guide their selection. 1, 21, 22 Understanding the full range of approaches for involving patients in MMS is essential as patients’ willingness to provide safety data, 23 and the barriers they encounter when providing safety data 23– 25 differ according to the data collection method used. Previous reviews have examined approaches to involving patients in MMS. For example, Madden et al. 26 and Li et al. 22 explored the psychometric properties and validity of patient-reported safety climate and participation questionnaires. Others have narrowed their scope to the reporting of adverse events, either by examining the means for eliciting these incidents 1 or by reviewing the technical reporting systems used to solicit those reports. 27– 29 Furthermore, Ramsey et al. 30 explored the qualitative perspectives of stakeholders regarding patient involvement in serious incident investigations. Despite these important contributions, the existing literature on involving patients in MMS remains limited by a focus on individual methods in isolation, leaving the full spectrum of patient safety data collection currently unexamined. Truly comprehensive MMS must be holistic and multidimensional, incorporating retrospective learning from past incidents with real-time data on the reliability of processes, the sensitivity to operations, and the capacity for organisational learning. 2, 31 Accordingly, considering the range of existing approaches, and the characteristics of, and evidence supporting, each approach is crucial for furthering the ability to involve patients in MMS on-the-ground. Objectives This review will employ an umbrella review methodology 32, 33 in order to identify, and develop an understanding of, existing approaches to involving patients in MMS that have been used within adult inpatient hospital care. Umbrella reviews allow for the integration of evidence from multiple systematic reviews to provide a comprehensive overview of a broad research area where several prior syntheses already exist. 32, 33 While a number of reviews in recent years have considered different means of involving patients in safety data collection, 1, 22, 26– 30 synthesising the full literature describing the various different approaches to involving patients in MMS will support an understanding of the extent of different approaches, their characteristics, and what might be recommended as current best practice for involving patients in MMS in hospital settings. Accordingly, our review question is as follows: What approaches to involving adult inpatients (or family/partners/carers communicating on their behalf ) in measuring and monitoring patient safety in hospitals have been used to-date, and what is the evidence supporting their use? The primary review objectives will be to: 1.Identify, and profile, all approaches that have been used to involve adult inpatients (or alternatively family, partners, or caregivers on their behalf ) in MMS in acute hospital-based care,2.Collate any data presented on the Acceptability (e.g., patient willingness to contribute within bedside safety interviews), Practicability (e.g., ease with which patients can access and use real-time feedback tools), Effectiveness/cost-effectiveness (e.g., rate of intercepted near-misses following patient input), Affordability (e.g., cost of implementing digital reporting platforms), Side-effects (e.g., potential strain on the patient-provider relationship), and Equity (e.g., accessibility of reporting mechanisms for vulnerable patients) 34 of approaches identified,3.Summarise any data presented on the psychometric evidence (i.e., validity, reliability and usability) of existing approaches and tools adopting a flexible approach that supports synthesis of both formal psychometric properties and practical utility data, and4.Identify barriers and facilitators to implementing and engaging with patient-informed safety measures in the inpatient acute care setting, according to the Capability, Opportunity, Motivation- Behaviour (COM-B) model. 35 1.Identify, and profile, all approaches that have been used to involve adult inpatients (or alternatively family, partners, or caregivers on their behalf ) in MMS in acute hospital-based care, Identify, and profile, all approaches that have been used to involve adult inpatients (or alternatively family, partners, or caregivers on their behalf ) in MMS in acute hospital-based care, 2.Collate any data presented on the Acceptability (e.g., patient willingness to contribute within bedside safety interviews), Practicability (e.g., ease with which patients can access and use real-time feedback tools), Effectiveness/cost-effectiveness (e.g., rate of intercepted near-misses following patient input), Affordability (e.g., cost of implementing digital reporting platforms), Side-effects (e.g., potential strain on the patient-provider relationship), and Equity (e.g., accessibility of reporting mechanisms for vulnerable patients) 34 of approaches identified, Collate any data presented on the Acceptability (e.g., patient willingness to contribute within bedside safety interviews), Practicability (e.g., ease with which patients can access and use real-time feedback tools), Effectiveness/cost-effectiveness (e.g., rate of intercepted near-misses following patient input), Affordability (e.g., cost of implementing digital reporting platforms), Side-effects (e.g., potential strain on the patient-provider relationship), and Equity (e.g., accessibility of reporting mechanisms for vulnerable patients) 34 of approaches identified, 3.Summarise any data presented on the psychometric evidence (i.e., validity, reliability and usability) of existing approaches and tools adopting a flexible approach that supports synthesis of both formal psychometric properties and practical utility data, and Summarise any data presented on the psychometric evidence (i.e., validity, reliability and usability) of existing approaches and tools adopting a flexible approach that supports synthesis of both formal psychometric properties and practical utility data, and 4.Identify barriers and facilitators to implementing and engaging with patient-informed safety measures in the inpatient acute care setting, according to the Capability, Opportunity, Motivation- Behaviour (COM-B) model. 35 Identify barriers and facilitators to implementing and engaging with patient-informed safety measures in the inpatient acute care setting, according to the Capability, Opportunity, Motivation- Behaviour (COM-B) model. 35 The development of this review question has been supported by application of the FINER criteria 36 to confirm it is appropriately feasible, interesting, novel, and relevant and will comprise a valuable addition to the research literature and a useful support for practice. Methods Review design and protocol registration Umbrella reviews (also commonly referred to as overview of reviews, review of reviews, meta-reviews 33, 37 ) serve to gather, assess, and synthesise evidence from multiple reviews on a specific topic, 33 in order to aggregate evidence across multiple syntheses, identify patterns in the results, and evaluate whether the existing reviews offer consistent or conflicting evidence. 32 This is important as multiple existing reviews on a given topic complicate evidence-based decision making and are challenging for end users to contend with. 33, 37, 38 Consequently, an umbrella review methodology was adopted, given their suitability for topics that have been researched or reviewed previously and for which the determination of evidence-based, or best, practice is important. Existing evidence syntheses in the area 1, 22, 26– 29 have been limited by a focus on individual methods and single dimensions of safety in isolation, 2 and an umbrella review will comprise an important support for progressing efforts to involve patients in MMS. This umbrella review will be conducted in line with the Joanna Briggs Institute (JBI) methodological guide for umbrella reviews 39 and best practice guidance for the conduct of umbrella reviews. 37– 39 Further, the review will be reported in accordance with the Preferred Reporting Items for Overviews of Reviews (PRIOR) checklist. 33 The current protocol was prepared as per the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) statement, 40 coupled with careful attention to the JBI Reviewer’s Manual 39 and PRIOR checklist. 33 The PRISMA-P checklist has been provided in Extended data, Appendix 1. The protocol was registered with the International Prospective Register of Systematic Reviews, PROSPERO (CRD420261351228). Search strategy Searches will be conducted across five electronic databases, specifically: MEDLINE (OVID); CINAHL (EBSCO); PsycINFO (EBSCO); Scopus (Elsevier), and; Academic Search Complete (EBSCO). The search strategy was developed by the research team, and includes Subject Headings as well as free-text keywords related to: 1) patient safety (e.g., exp Patient Safety/, ‘patient safety’, ‘patient harm’), 2) patient, family, partner and carer involvement (e.g., exp Patient Participation/, ‘patient participation’, ‘family involvement’), and 3) the use of a review methodology (e.g., ‘systematic review’, ‘meta-analysis’). A search strategy was initially developed for MEDLINE (see Table 1 for MEDLINE search strategy) and adapted as necessary for use in the other databases (see Extended data, Appendix 2 for search strategies used across all electronic databases). The development of the search strategy was informed by consideration of previous reviews of patient-report patient safety measurement tools that were known to the review team, 1, 3, 22, 26– 29 as well as umbrella reviews of measurement tools for use in healthcare. 41– 43 In addition, the search strategy has been reviewed and agreed by a University research librarian. Consideration of PRESS (Peer Review of Electronic Search Strategies 44 ) and reporting standards for literature searches by Atkinson and colleagues’ 45 has supported us in ensuring search quality, transparency and replicability. No limits on the year of publication will be applied in the database searches and, as such, studies published from inception to April 2026 will be eligible for inclusion. Table 1. Search strategy for Medline (OVID) database. 1. exp Patient Safety/ 2. exp Patient Harm/ 3. (patient* adj1 (harm or safe*2)).ti,ab. 4. exp Medical Errors/ 5. ((medic* or human or health?care) adj1 error*1).ti,ab. 6. (preventable or avoidable or unintended or unnecessary) adj1 (harm or consequence*1).ti,ab. 7. (safe*2 adj1 (care or culture or climate or opportunit*)).ti,ab. 8. exp Iatrogenic Disease/ 9. (iatrogenic adj1 (harm or disease)).ti,ab. 10. 1–9/OR 11. Exp Systematic Review/ 12. Exp Scoping Review/ 13. Exp Meta-Analysis/ 14. ((systemati* or scoping or rapid or literature) adj1 review).ti,ab. 15. (meta?analys*).ti,ab. 16. (meta adj1 analys*).ti,ab. 17. ((search* or synthes*) adj3 (literature or research or evidence or database*1)).ti,ab. 18. 11–17/OR 19. exp Patient Participation/ 20. exp Patient Reported Outcome Measures/ 21. ((patient*2 or family or families or carer*1 or partner*1) adj2 (participation or perception* or perceive* or report* or involv* or engag* or concern* or complain* or comment* or review* measure* or monitor* or feedback or input* or survey* or questionnaire* or knowledge or insight*1 or interview*2 or experience*1 or access*)).ti,ab. 22. 19–21/OR 23. 10 AND 18 AND 22 Search strategy for Medline (OVID) database. To complement electronic database searches, both backward and forward citation searching, as per best practice recommendations, 46 will be employed. First, the reference lists of all studies deemed eligible for inclusion following the initial electronic searches will be screened. Similarly, the reference lists of a previous umbrella review 8 and systematic reviews 47– 50 that explored patient engagement in healthcare safety more broadly will also be reviewed to identify any additional relevant review papers. Second, using the included studies and the aforementioned reviews, 8, 47– 50 we will conduct forward citation searching using Scopus and Google Scholar. These two citation indexes were selected to ensure a comprehensive capture of more recent work. All records identified through these methods will be tracked and reported separately in the PRISMA flow diagram. 46 Eligibility criteria Eligibility criteria are outlined according to the PICo-T format for umbrella reviews, 39 comprising the Population (P), Phenomena of Interest (I), Context (Co), and Types of Studies (T). Accordingly, our eligibility criteria are as follows: Population. The population of interest, within relevant reviews, will include adults (defined as individuals aged over 18 years) receiving care within an inpatient hospital setting. Recognising the valuable insight of the patient’s family and carers, we will also include reviews that engage family members, partners, or carers in the patient’s stead. Conversely, we will exclude reviews that focus solely on the MMS safety through engagement with other stakeholders, such as healthcare providers, without direct patient, family or carer involvement. Further, while some reviews may span multiple healthcare settings (e.g., both paediatric and adult populations), we will exclude those where data specific to adult inpatients cannot be clearly extracted. Phenomena of Interest . The phenomenon of interest is the involvement of patients (or family members, partners, or carers) in MMS in inpatient hospital care settings. For reviews which describe a broader focus on patient involvement in patient safety (e.g., interventions designed to enhance safety through patient participation, of which involving patients in MMS is just one potential form/element), two independent reviewers will systematically consider the full-text manuscript to determine whether a clear focus within the study (e.g., within the study aim or data extraction) relates to patient involvement in MMS, and whether substantive, relevant data on such approaches are included and can be extracted. Reviews that describe a method to collect quality-of-care data more broadly from patients, their families or carers (e.g., patient portals, review of notes, beside handovers), which explicitly frame or propose the method as a potential means of collecting safety data from patients will also be included. Conversely, we will exclude reviews that do not specifically synthesise approaches to MMS from the patient, family, partner or carer perspective. Reviews relevant to the topic of patient involvement in patient safety that do not provide detail on methods for eliciting safety information from patients, including reviews focused on factors influencing patients’ feeling of safety, predicting patient’s willingness and ability to be involved, or experiences of involvement will be excluded. Similarly, reviews focused on patient interventions that aim to improve the safety of care (as opposed to interventions focused on collecting safety data; e.g., interventions focused on educating patients, encouraging patients to ‘speak up’) will also be excluded, as well as those that only summarise findings resulting from patient reports without providing a detailed description of the methods used to collect such data. Further, reviews that provide no detail beyond naming, listing or briefly noting methods for collecting safety data directly from patients, their families or carers (e.g., surveys and interviews were used to examine experiences of adverse events) without detail on its usability, appraisal of its reliability or validity, or detail/consideration of its implementation will be excluded. We will also exclude reviews where the focus of the approaches, tools, or instruments are broader than patient safety (e.g., general quality of care or patient experience), unless they contain at least one patient safety-specific subscale or section for which data can be extracted, or are explicitly framed or positioned, by the authors, as a tool for collecting safety data from patients and their proxies. Finally, we will exclude reviews of studies that rely upon soliciting patient input in response to hypothetical vignettes and scenarios only, or those designed to capture general opinions on patient safety rather than focusing on specific patient experiences, and the elicitation of these, related to safety. Context . This umbrella review is specifically focused on patient safety within the context of adult inpatient hospital care. We define patient safety in accordance with the World Health Organisation 56 as “the prevention of errors and adverse effects to patients associated with health care.” Inpatient hospital care is characterised by the formal admission of a patient to a healthcare facility for treatment, diagnostic tests, or surgical procedures requiring a stay of at least one night (typically 24 hours) that concludes with a formal discharge, occurring when the patient returns home, is transferred to another facility, or in the event of death. 57, 58 While we recognise the importance of safety across the continuum of care, other healthcare domains, including primary and community care, outpatient care (or procedures most commonly performed in the outpatient setting (e.g., diagnostic endoscopies)), paediatric care, mental health and psychiatry, maternity and obstetric care, and transitions of care from the hospital to the home care setting differ significantly in their patient population, and clinical and operational structures. Consequently, research relating to these settings, falls outside the scope of this review. Finally, reviews focused exclusively on adverse drug reactions (ADRs) or pharmacovigilance tracking (and not medication errors more broadly), or national incident reporting systems that are not specific to the hospital setting or where the setting is unclear will also be excluded. Study Type . Systematic reviews and reviews of any design type (e.g., scoping reviews, rapid reviews) with an explicit methods section and evidence of a systematic search strategy in at least two databases will be included, similar to previous mixed-method umbrella reviews of healthcare research. 59– 61 Narrative review articles that do not follow a systematic approach, and primary studies will be excluded. There will be no restriction by country or publication year, though publications are required to be peer-reviewed and written in the English language. Study selection Studies retrieved in electronic database searches will be first exported into Endnote© ( https://end-note.com/; Zotero ( https://www.zotero.org/) may be considered as a free alternative that can perform equivalent functions) to support the removal of duplicate studies as per Bramer et al.’s de-duplication process. 62 Subsequently, all remaining records will be exported to Microsoft Excel© ( https://www.microsoft.com/en-ie/microsoft-365/excel; Google Sheets ( https://www.google.com/sheets/about/) may be considered as a free alternative that can perform equivalent functions) and screened according to their titles and abstracts. ROM and SL will first pilot the eligibility criteria on a random sample of the titles and abstracts of 10 reviews, similar to Moens et al. 42 Subsequently, ROM will screen the remaining returns, whereby the full texts of articles judged to meet the inclusion criteria, or where there was insufficient information to determine eligibility, will be retained for full-text review. These will be screened by ROM and a final decision on inclusion will be made. During the full-text screening stage, the specific reasons for the exclusion of any studies will be systematically documented within Microsoft Excel© and summarised in the final PRISMA flow diagram 63 to ensure methodological transparency and rigor. If there is ambiguity surrounding the suitability of an article, this will be discussed by the two authors (ROM and SL), in consultation with the wider research team where necessary, until consensus is achieved. Data extraction A data extraction form, informed by previous umbrella reviews 8, 42, 43 and systematic reviews of patient involvement in patient safety 1, 22, 26 has been developed. Table 2 presents the full range of variables for which data will be extracted. The form will be piloted in advance of beginning formal data extraction by two authors (ROM and SL). Where data are missing, this will be reported in the final review. Duplicate data extraction will be independently completed by two authors for each study, with disagreements resolved by discussion until consensus is achieved. Table 2. Data extracted from the included review studies and method of synthesis.VariablesDescriptionsCoding Data on the review’s methodology and findings Author(s) Last names of the author(s) of the reviewN/A Publication year The year in which the review was publishedN/A Review aim(s) The research questions, aims, and/or objectives of the reviewClassified into Analyse data resulting from the approach/ tool, Methods used to measure safety, Where the approach/ tool is used and with whom, When the approach/ tool is administered, Use of resulting data to support improvement, Learning for implementation of approach/ tool into practice, Outcomes of implementation. Period covered The publication period covered by the included primary studiesN/A Number of included studies The number of primary studies included in the reviewN/A Quality assessment The assessment tool used by the author(s) to evaluate the quality of the included studies, and the score and interpretation of the quality of the included studiesN/A Data on approach/tool to involving patients in measuring patient safety Name of tool/approach The name (if any) of the approach (es)/tool(s) discussed in the reviewN/A Type of safety measure The type of approach (es)/tool(s) used to collect data from patientsClassified through a deductive-inductive approach, 51, 52 with coding informed by existing frameworks, 43, 53, 54 while also allowing for novel types of approaches/methods to emerge de novo from the data. Description A short description of the approach (es)/tool(s) as reported by the author(s)N/A Administration and mode of delivery When and how often the measurement was administered The medium or format through which the tool is administered (e.g., paper-based survey, face-to-face interview), and whether the user’s identity is known The people responsible for administering the approach/tool to the participantsTiming classified as administered during stay, around discharge, post-discharge Frequency classified as once-off, continuous access, discrete event but repeated Protection classified as known, anonymousFormat classified as face to face, mailed, telephone, online Administrator classified as clinical staff, managerial/administrative staff, dedicated staff/researchers Dimension of safety and type of safety issue The specific nature of the safety incident or risk the tool is designed to identify, monitor, or mitigate The specific nature of the safety incident or risk the tool is designed to identify, monitor, or mitigateStructure of the tool and the nature of user engagementDimension of safety classified into past harm, reliability of safety critical processes, sensitivity to operations, anticipation and preparedness and integration and learning, according to the Measuring and Monitoring Safety (MMS) framework 4, 31 Type of safety issue(s) classified as Broad safety issues (e.g., perceptions of safety on a ward), Specific safety issues (e.g., errors related to medication), and/or Wider issues (e.g. quality, positive experiences in care) Engagement with tool classified as proactive vs reactive Structure of tool classified as open-ended, guided or structured Development of approach (es)/tool(s) The origin of the tool, including whether it was newly created for the study, adapted from an existing framework, or used in its original validated form. Detail on the design process, theoretical underpinning, or pilot testing used by the authors.N/A Participants and setting The participants who used the approach/tool to provide safety data The hospital setting in which the tool was used The country in which studies are basedParticipants using the measure classified as Patients only, Patients and family, Patients and carers, Patients, family and carers Setting classified as Unit, Hospital, Multi-site, Health service Data on the validity and feasibility of the approach (es)/tool(s) Evidence on the feasibility and appropriateness of approach/tool All information reported on the Affordability, Practicability, Effectiveness/cost-effectiveness, Acceptability, Side-effects, and Equity of approachesClassified into Affordability, Practicability, Effectiveness/cost-effectiveness, Acceptability, Side-effects, and Equity, according to the APEASE framework 34 Psychometric properties of approach/tool The framework used by the author(s) to organise psychometrics-related evidence for the approach/tool and/or the approach/tool’s psychometric properties that were reviewed (only relevant if the authors categorised the psychometric evidence) All the information reported regarding the tool’s psychometric properties.Classified into the following categories: validity, reliability, and usability, as per Moens et al. 42, 55 Barriers and facilitators Data pertaining to the barriers and facilitators influencing how adult inpatients, families, and healthcare staff engage with patient-informed safety measures will be coded according to the COM-B (Capability, Opportunity, Motivation- Behaviour) modelClassified into Capability, Opportunity, and Motivation 35 Data extracted from the included review studies and method of synthesis. Methodological quality assessment The methodological quality of the included reviews will be critically appraised using the Critical Appraisal Skills Programme (CASP) systematic review checklist. 64 The CASP systematic review checklist focuses on the methodological validity and practical relevance of a review. 64 The CASP checklist was selected for its explicit guidance and methodological flexibility 65– 67 and ability to accommodate various review types, such as rapid and scoping reviews, without compromising on rigor. 64 The CASP checklist has been successfully applied in previous umbrella reviews of measurement tools. 42, 43 The CASP checklist has three parts: part A, are the results of the study valid? (five items); part B, what are the results? (two items); and part C, will the results help locally? (three items). Similar to previous umbrella reviews of measurement tools, 42, 43 two items will not be applied in our appraisal as they are specifically relevant to interventions: (7) “How precise are the results?”; and (8) “Can the results be applied to the local population?”. CASP items require a response of ‘yes’ (1 point), ‘no’ (0 points), or ‘can’t tell’ (0 points), returning a total score out of 7. To ensure accuracy, two reviewers will complete the quality appraisals for each review study in tandem, and any disagreements will be resolved through discussion or consultation with a third reviewer. Certainty of evidence To assess the certainty of evidence, we will employ a dual-framework approach, applying GRADE 68, 69 to quantitative outcomes and GRADE-CERQual 70, 71 to qualitative findings. While some have advised against appraising the certainty of the evidence in mixed methods reviews, 72, 73 organisations such as the National Institute for Health and Care Excellence support the complementary use of GRADE and GRADE-CERQual 74 frameworks, and these frameworks have been applied in previous healthcare systematic and umbrella reviews. 75– 81 Applying both frameworks will provide a more robust and holistic evidence base for decision-making than a single-framework assessment could achieve. 82 This assessment will be conducted at the level of each distinct approach to measurement (e.g., surveys, interviews, incident reporting) to determine the robustness of each method identified. Following established methodological guidance, 69, 71 each approach will begin with a ranking of High certainty and is downgraded to Moderate, Low, or Very Low based on serious concerns across standardised domains. For quantitative data, downgrading will be based on methodological quality (informed by CASP scores), inconsistency of results across reviews, indirectness of the evidence, imprecision in findings, and potential publication bias. 68, 69 For qualitative data, confidence will be evaluated based on methodological limitations, the coherence of findings, the adequacy of the data, and the contextual relevance. 71 Two reviewers (ROM and SL) will perform these assessments in tandem, with discrepancies resolved through discussion (as is recommended when using the GRADE-CERQual 71 ) and consultation with a third reviewer where necessary. The final certainty ratings for each approach will be summarised in Summary of Findings tables 68– 71 to facilitate evidence-based decision-making. If both quantitative and qualitative data are provided for a specific data variable (e.g., qualitative and quantitative data for effectiveness/cost-effectiveness), a convergent-segregated approach will be conducted by performing separate quantitative and qualitative syntheses, then integrating the results derived from each of the syntheses. 74, 83 Data synthesis Given the anticipated diversity within the review papers included, content analysis 84 will be undertaken to synthesise the extracted data. This involves the development of categories/codes either de novo or through engagement with existing theories that are applied through the consideration of data extracted from each distinct study. 85 It is anticipated that content analysis will be used as part of data extraction and synthesis. This will comprise an initial stage of data synthesis, and will allow us to bring consistency of language across studies and extracted data and facilitate later comparison of studies. To ensure reviewer consistency, the initial coding framework will be first piloted on five studies by two authors (ROM and SL) and refined as necessary. The two authors will meet frequently throughout the data extraction process to carefully compare records, align data, and discuss category refinement and coding inconsistencies in detail. In instances where reviewers failed to come to a clear consensus regarding coding disagreements, an additional member of the research team will be consulted (CM and POC). As presented in Table 2, it is anticipated that data pertaining to the following variables will be coded deductively by two authors independently during this process: Methods of measurement. Approaches to MMS from the perspective of patients, family members, and carers will be categorised using a hybrid deductive-inductive approach. 51, 52 While initial categorisation is informed by established frameworks (e.g., surveys, interviews, incident reporting, and record reviews) 43, 53, 54 ; this review recognises that these frameworks are largely derived from healthcare provider perspectives. Consequently, the classification will remain flexible and iterative, allowing for the identification and inclusion of novel, patient-led measurement approaches (e.g., narrative storytelling, real-time digital feedback) that may not be captured by traditional, healthcare professional-focused taxonomies. Dimension of safety. The dimension of patient safety measured by the study’s approach to safety measurement will be coded according to the five dimensions of the MMS framework, 2, 31 which includes past harm, reliability of safety critical processes, sensitivity to operations, anticipation and preparedness, and integration and learning. This framework is well-established in safety research as it allows for a multidimensional understanding of safety, which moves beyond retrospective incident reporting toward a more holistic, proactive view of safety system performance. 2, 31 Consequently, it is commonly used in reviews examining the MMS in healthcare. 43, 53, 54 Feasibility and contextual appropriateness. Data provided on the feasibility and contextual appropriateness of the approaches to measurement will be coded according to the APEASE (Affordability, Practicability, Effectiveness/cost-effectiveness, Acceptability, Side Effects/Safety, Equity) framework. 34 Within the context of patient-informed safety measures, the criteria are defined, and understood, as follows: Affordability considers the institutional costs to implement patient-facing safety measures; Practicability evaluates the operational ease at which safety measures can be implemented into practice and used by patients or their proxies; Effectiveness/cost-effectiveness examines how successfully patient-reported data intercepts near-misses or reduces adverse events, or the impact of these tools relative to implementation costs; Acceptability assesses the willingness of adult inpatients, families, and healthcare staff to engage with and act on patient safety feedback; Side-effects monitors unintended consequences, such as increased nursing workflow burdens or strain on patient-provider relationships; and Equity addresses the accessibility of reporting mechanisms for vulnerable adult populations. The APEASE framework provides a structured lens to evaluate not just if a tool works in a vacuum, but if it is viable for use by patients, and their families, within the complex environment of an acute hospital. 34 When evaluating methods of MMS, the APEASE criteria provide a methodical way of assessing the acceptability, feasibility and contextual appropriateness of such approaches, 34 in that, if all six criteria are achieved then an approach or intervention is more likely to be successful and lead to behaviour change (i.e., patients will use the approach to provide safety data). 86 Psychometric evidence. Evidence reported regarding the approach’s/tool’s psychometric properties will be categorised as validity, reliability, or usability, similar to the approach undertaken in Moens et al. 42, 55 Validity is considered a unified concept addressing the appropriateness of inferences or decisions made from measurement (e.g., content, construct, or criterion validity in capturing patient safety insights); Reliability refers to the overall consistency and stability of a measure when repeated under consistent conditions (e.g., internal consistency or inter-rater reliability), and Usability addresses practical features and operational feasibility of using the measure in practice (e.g., time requirements, clarity of instructions, ease of interpreting results, and completion rates by adult inpatients or their carers). Recognising that included reviews may vary significantly in their depth of reporting, we will not apply a rigid, granular psychometric threshold (e.g., as used in specialised tool-validation reviews like COSMIN 87 ). Instead, we will adopt a flexible approach that accounts for the anticipated diverse nature of identified methods. Many approaches to involving patients in MMS, such as patient-report surveys (often targeting past harm or anticipation and preparedness dimensions of the MMS framework 2, 31 ) may provide substantive psychometric data (e.g., the reviews by Madden et al. 26 and Li et al. 22 ). Conversely, emerging measurement approaches, particularly those aimed at assessing the ‘sensitivity to operations’ or ‘integration and learning’ dimensions of the MMS framework (e.g., safety walk-rounds or the integration of safety lessons into practice 2, 31 ), may prioritise practical utility and contextual responsiveness over formal psychometric properties. 1 Anticipating this variation, our synthesis will capture the breadth of evidence available, ensuring we do not inadvertently emphasise formal validation at the expense of capturing innovative, patient-informed approaches that are essential for holistic safety monitoring. 4 Barriers and facilitators. Data pertaining to the barriers and facilitators influencing how adult inpatients, families, and healthcare staff engage with patient-informed safety measures will be coded according to the COM-B (Capability, Opportunity, Motivation, and Behaviour) model. 35 The COM-B model proposes that behaviours related to engaging with patient-informed safety measures are influenced by an individual’s capability, opportunity, and motivation. Capability evaluates whether individuals possess the capacity (e.g., psychological knowledge and physical skills) required to engage with safety measures; Opportunity examines the external factors that encourage or impede engagement, including the physical (e.g., the availability of bedside digital tablets) and social environment (e.g., a ward culture that actively encourages patient input); and Motivation assesses the internal psychological processes that direct or inhibit engagement with safety measures, including conscious beliefs about the tool’s clinical utility, confidence in speaking up, and emotional barriers such as anxiety about reprisal. This model provides a structured, theory-driven approach to evaluate not just the practical mechanics of a safety measure, but the underlying behavioural mechanisms that drive or inhibit its active use by patients, families, and staff within the complex environment of an acute hospital. 35 Following this, a narrative synthesis approach will be undertaken to analyse the resulting data, guided by Popay et al.’s 88 approach to narrative synthesis. A meta-analysis will not be performed as the focus of umbrella reviews remains on summarising existing evidence syntheses rather than generating new pooled estimates. 39 Accordingly, different methods and tools will be used as part of this narrative synthesis, such as text-based summaries of studies, the categorisation of similar studies, the use of tables and figures to present summary data, and the transformation of data using content analysis. 88 We will assess and narratively report the overlap of primary research studies across the included reviews to ensure transparency and clarity regarding the evidence base for readers. 33 As the primary focus of this review is a narrative synthesis of methodology rather than a detailed meta-analysis of interventions, the analysis will adhere to a similar approach used in other umbrella reviews of measurement tools 41– 43 and, so, the presentation of data will focus on clear, thematic categorisation. To ensure the accurate synthesis of complex findings, data extraction and synthesis will be conducted by experienced researchers holding PhDs with extensive backgrounds in diverse systematic review methodologies. This advanced expertise, paired with a high level of continuous contact and thorough comparative analysis throughout the dual data extraction process, ensures the research team is well-equipped to manage, and communicate, analytical complexities and present the final data in an accessible and interpretable format for readers and users. Patient and Public Involvement (PPI) This umbrella review is part of a wider programme of research (the Patient Involvement in Patient Safety (PIPS) project), the development of which was supported by the Irish Centre for Applied Patient Safety and Simulation’s (ICAPSS; https://www.universityofgalway.ie/icapss/) established PPI group. The research team, and protocol authorship, includes a patient representative (WR) who has contributed to protocol development and will support completion of the review. Further, PPI members will contribute to the development of accessible, lay-friendly summaries of the review’s findings, ensuring the findings can engage members of the public. Discussion Summary . This umbrella review aims to identify all existing approaches to involving adult inpatients (or family/partners/carers communicating on their behalf ) in MMS in hospital settings, along with elucidating evidence supporting their use. Data will be synthesised as to understand the different approaches that exist to measuring patient safety from the patient’s perspective (e.g., surveys, incident reporting, or novel patient-led approaches) and the dimensions of safety targeted within these, along with any available evidence pertaining to the feasibility, contextual appropriateness and psychometric properties of existing approaches. It will further consider any existing evidence on barriers and facilitators that might influence patient, family, or staff engagement within the different methods identified. Expected outcomes . Based on similar umbrella reviews of measurement tools, 41, 43 it is expected that this umbrella review will deliver four key outcomes: a comprehensive summary of existing patient-, family- and carer-facing safety measurement methods (such as surveys, bedside interviews, and digital reporting platforms); a multi-dimensional evidence synthesis aligning, and balancing, psychometric properties (validity, reliability, and usability) with practical feasibility via the APEASE framework for each category of measurement method; a theory-driven mapping of the behavioural and psychological barriers and facilitators influencing patient, family, and staff engagement with these safety measures; and context-specific guidance on best practice for involving patients or their proxies in safety measurement to help clinical practitioners and researchers select feasible, psychometrically sound tools for acute care hospital wards. Ultimately, these outcomes will provide an actionable foundation for integrating the patient’s voice into real-time hospital safety surveillance. Limitations . As an umbrella review, the quality of our findings will be inherently dependent on the depth and rigor of the included reviews. Any omissions or data extraction errors in the original reviews will be reflected in this synthesis. Furthermore, by restricting our scope to existing reviews, we may overlook primary studies published very recently that have not yet been captured in a systematic synthesis. Additionally, while we focus on adult inpatient care, many existing reviews aggregate data across diverse healthcare settings (e.g., primary care, paediatrics, and maternity). The challenge of de-aggregating these data may limit the depth of setting-specific insights we can provide for the hospital setting. There is significant variability in how patient-involved safety measurement is defined, ranging from real-time bedside interviews to retrospective surveys. This heterogeneity, combined with the diverse psychometric properties of the tools, may make direct comparisons or the synthesis of data challenging. The exclusion of non-English language reviews may introduce a degree of publication bias. These factors will be considered when interpreting the findings of this review. Implications. Implications for best practices in hospital-based safety monitoring, healthcare policy, and future research, such as the need for more robust psychometric and feasibility testing, will be presented. Any limitations of the reviews included, such as a surface-level consideration of included studies, or a failure to consider important aspects of approaches such as APEASE variables or usability, as well as limitations of the umbrella review itself, will be transparently outlined. We anticipate that these findings will be used to inform international recommendations for best practices in patient-involved safety measurement and to guide the development, and testing, of more effective, real-world monitoring systems in adult inpatient settings. Dissemination The findings of this umbrella review will be disseminated through the publication of a peer-reviewed manuscript. Additionally, findings will be presented via conference presentation(s) both nationally and internationally. We will also ensure, with the support of our PPI contributors, that the findings are disseminated appropriately to engender public engagement also. No further comments. Author addressed the comments. Is the study design appropriate for the research question? Yes Is the rationale for, and objectives of, the study clearly described? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Partly Reviewer Expertise: Patient safety, communication, healthcare inequality, evidence synthesis, health services research. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. The revised version of the current study protocol almost entirely fulfil all the recommendations made by the reviewers. It is now more scientifically valid and relevant to the topic. By defining the study population as adult inpatients, family, partners and/or carers in acute care, it is now easy to identify the exact study population. The title has revised including study population and the method to be used. The revised introduction section is now more preciously raises the research questions with three identified objectives and the relevant background information. The detail methodology highlighting eligibility criteria, search strategy, data extraction, coding, synthesis and analysis methods enlighten this section than previous one. Inclusion of possible outcome, limitations, barriers and facilitators, and impacts enriched the study protocol. Overall, the revised study protocol may be accepted with minor English language editing in few places. Is the study design appropriate for the research question? Partly Is the rationale for, and objectives of, the study clearly described? Yes Are sufficient details of the methods provided to allow replication by others? Partly Are the datasets clearly presented in a useable and accessible format? Partly Reviewer Expertise: Hospital Administration, Patient safety, Health technology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. The study protocol described here, is an important and vital topic of patient safety. The rationale and the objective were narrated with relevant citations. Following few suggestions may be considered as below to improve the study, - 1. The title should specify what is mean by 'patient safety in hospitals' i.e. there should be a clear boundary of the study population. Whether pre & post hospital care included or not, though protocol specify adult over 18 years with no upper limit, whereas, vulnerable group have more risk, 2. Based on the three main objective, first one is of identity and demographic profile in MMS in hospital based care, needs clarity as stated above. Second objective based on APEASE approach, but more details on methodology of each variable needs to be described properly. Third objective specifically based on psychometric evidence only, but what method used not clearly mentioned. 3. The methods section need more explanation on how the data collected as stated above and what method used to analyse need to mentioned. 4. A short note on expected outcome may be added. Is the study design appropriate for the research question? Partly Is the rationale for, and objectives of, the study clearly described? Yes Are sufficient details of the methods provided to allow replication by others? Partly Are the datasets clearly presented in a useable and accessible format? Partly Reviewer Expertise: Hospital Administration, Patient safety, Health technology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. The study protocol described here, is an important and vital topic of patient safety. The rationale and the objective were narrated with relevant citations. Following few suggestions may be considered as below to improve the study, - Thank you for your constructive review of our umbrella review protocol. We have found your suggestions and comments helpful and have provided a point-by-point response to your feedback below. 1. The title should specify what is mean by 'patient safety in hospitals' i.e. there should be a clear boundary of the study population. Whether pre & post hospital care included or not, though protocol specify adult over 18 years with no upper limit, whereas, vulnerable group have more risk, Answer: The authors have revised the Title to clearly specify the study population as "adult inpatients... in acute care hospital settings," thereby explicitly excluding pre- and post-hospital care. We hope that this is satisfactory to the reviewer. 2. Based on the three main objective, first one is of identity and demographic profile in MMS in hospital based care, needs clarity as stated above. Second objective based on APEASE approach, but more details on methodology of each variable needs to be described properly. Third objective specifically based on psychometric evidence only, but what method used not clearly mentioned. Answer: We appreciate the reviewer drawing our attention to a lack of clarity within the three main objectives. For Objective 1, in line with the updates made to the title and scope, we have revised the first objective to explicitly reflect our focus on adult inpatients within acute care hospital settings. For Objective 2, we have provided further detail, and have described concrete, context-specific examples for each criterion (e.g., patient willingness to contribute within bedside interviews for Acceptability) offering clarity on the structured and rigorous evaluation we will conduct of how these safety measures function within acute care environments. For Objective 3, we have offered more detail on plans to summarize psychometric evidence. In addition to these objectives, we have outlined an additional fourth objective that our review will seek to address (i.e., to identify barriers and facilitators to implementing and engaging with patient-informed safety measures in the inpatient acute care setting). We hope these changes will be satisfactory to the reviewer. We have tried to balance providing important information with offering clear, reader-friendly, and concise objectives. We believe this, coupled with additional detail added to the method section, provides the necessary information for readers. 3. The methods section need more explanation on how the data collected as stated above and what method used to analyse need to mentioned. Answer: We appreciate the reviewer's feedback. We have expanded the Data synthesis section of the Methods to provide a more comprehensive explanation of our data collection and analysis procedures. Specifically, we have contextualized the data extracted related to the APEASE criteria, by integrating explicit operational definitions for all six dimensions of the APEASE framework in the context of patient-informed safety measurement in acute hospital settings (see Data synthesis, Feasibility and contextual appropriateness). Furthermore, we have clearly defined how the psychometric properties of validity, reliability, and usability will be operationalized and categorized within our synthesis framework (see Data synthesis, Psychometric evidence). These additions clarify both the specific types of data that will be extracted and the thematic structure that will guide our qualitative analysis. In addition to these revisions, the Data synthesis section also outlines how we will extract and synthesize data related to our newly-added fourth objective. Specifically, we describe how barriers and facilitators to implementing and engaging with patient-informed safety measures in the inpatient acute care setting will be categorized using the behavior theory framework referred to as the COM-B (Capability, Opportunity, Motivation- Behaviour) model (see Data synthesis, Barriers and facilitators). 4. A short note on expected outcome may be added. Answer: The authors agree that a short note on the expected outcomes of this review would be useful to readers. We have updated the manuscript to include a dedicated "Expected Outcomes" section within the Discussion to clearly outline the explicit contributions of this review. Specifically, we have summarized the four key structural outputs of our synthesis: a comprehensive categorization of existing patient- and family-facing safety measurement tools; a multi-dimensional evidence synthesis balancing psychometric properties with the APEASE feasibility framework; a theory-driven mapping of the behavioral barriers and facilitators to patient involvement in safety data collection, using the COM-B model; and context-specific best-practice guidance for researchers and clinicians (see Discussion, Expected outcomes). This addition clearly highlights how the review will provide an actionable foundation for integrating the patient's voice into safety surveillance. The protocol is generally well structured, methodologically rigorous, and aligned with established guidance for umbrella reviews. The review addresses an important and timely topic and demonstrates strong engagement with relevant methodological frameworks. The rationale for the review is generally clear and well developed. However, some statements within the introduction appear somewhat overstated. In particular, the claim that patient safety initiatives have “largely ignored” the patient voice does not fully acknowledge the growing international emphasis on patient-centred care and patient engagement in safety. The introduction would benefit from a more balanced discussion distinguishing general patient involvement from involvement specifically in safety measurement and monitoring. The methods are described in substantial detail and are generally sufficient to allow replication. The protocol clearly outlines the search strategy, eligibility criteria, screening procedures, quality appraisal methods, and synthesis approach. However, the temporal coverage of database searches is not clearly specified, and reporting the search timeframe would improve transparency and reproducibility. In addition, further clarification regarding the inclusion criteria for “comprehensive reviews” beyond systematic reviews would strengthen methodological transparency. The proposed flexible coding strategy is appropriate given the anticipated heterogeneity of approaches. However, additional detail regarding how coding disagreements, category refinement, and reviewer consistency will be managed would further improve reproducibility. As this is a protocol, no final datasets or synthesis outputs are yet available for evaluation. Nevertheless, the manuscript would benefit from additional detail regarding how complex findings and overlap between included reviews will be presented in accessible and interpretable formats. Overall, this is a strong and methodologically sound protocol with clear potential to make an important contribution to the patient safety literature. Is the study design appropriate for the research question? Yes Is the rationale for, and objectives of, the study clearly described? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Partly Reviewer Expertise: Patient safety, communication, evidence synthesis, health services research. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. The protocol is generally well structured, methodologically rigorous, and aligned with established guidance for umbrella reviews. The review addresses an important and timely topic and demonstrates strong engagement with relevant methodological frameworks. Thank you for your constructive and kind review of our protocol, we believe your suggestions have strengthened the clarity and focus of our review further. 1. The rationale for the review is generally clear and well developed. However, some statements within the introduction appear somewhat overstated. In particular, the claim that patient safety initiatives have “largely ignored” the patient voice does not fully acknowledge the growing international emphasis on patient-centred care and patient engagement in safety. The introduction would benefit from a more balanced discussion distinguishing general patient involvement from involvement specifically in safety measurement and monitoring. Answer: The authors thank the reviewer for this insightful comment. We have revised the introduction to provide a more nuanced, balanced background to our work. Specifically, we tempered claims around the exclusion of the patient voice and now explicitly acknowledge the growing international emphasis on patient empowerment and patient-centred care (see Intro, paragraph 1). Further, we have improved clarity by explicitly distinguishing general patient involvement in healthcare decision-making (e.g., treatment preferences, clinical plans, and self-management) from the specific mechanism of involving patients and their families directly in patient safety measurement (see Intro, paragraph 2). We believe these changes offer a much more balanced rationale for the current review. 2. The methods are described in substantial detail and are generally sufficient to allow replication...However, the temporal coverage of database searches is not clearly specified, and reporting the search timeframe would improve transparency and reproducibility. Answer: The authors agree that explicitly outlining the search timeframe would further enhance the transparency and reproducibility of our search strategy. Within the Search strategy section of the methodology (see Search strategy, paragraph 1), we have updated the text to clarify that no publication year limits will be applied, explicitly stating that the searches will cover literature from database inception up to April 2026. 3. In addition, further clarification regarding the inclusion criteria for “comprehensive reviews” beyond systematic reviews would strengthen methodological transparency. Answer: The authors agree that the term ‘comprehensive reviews’ is somewhat unclear. In the revised manuscript, we have removed the ambiguous term “comprehensive reviews” and state that eligible reviews of any design type will be eligible for inclusion if they include an explicit methods section and demonstrate a systematic search strategy across at least two databases (see Eligibility criteria, Study type, paragraph 1). We hope the reviewer agrees that this is now more clearly presented. 4. The proposed flexible coding strategy is appropriate given the anticipated heterogeneity of approaches. However, additional detail regarding how coding disagreements, category refinement, and reviewer consistency will be managed would further improve reproducibility. Answer: The authors thank the reviewer for this suggestion. To maximize the reproducibility and rigor of our analysis, we have expanded the Data synthesis section of the methods to explicitly detail how coding consistency, category refinement, and disagreements will be managed (see Data synthesis, paragraph 1). We have clarified our process and now detail a formal pilot of the coding framework on an initial sample of five studies, a structured meeting procedure between the two primary extractors to align data and refine categories, and the process for resolving instances where a consensus cannot be reached (i.e., consultation with additional members of the research team). 5. As this is a protocol, no final datasets or synthesis outputs are yet available for evaluation. Nevertheless, the manuscript would benefit from additional detail regarding how complex findings and overlap between included reviews will be presented in accessible and interpretable formats. Answer: Within the Data synthesis section of the manuscript, we describe how we will assess and report the overlap of primary research studies across the included reviews to ensure clarity on the evidence base being considered is offered. Further, we have specified that because this review focuses on a narrative synthesis of methodology rather than a meta-analysis of quantitative data, the presentation of data will centre on clear, thematic categorisation in line with similar umbrella reviews of measurement tools (Lorente et al., 2020; Moens et al., 2026; O’Connor et al., 2021). Lastly, we have highlighted that the data extraction and synthesis will be conducted by experienced researchers with advanced backgrounds in systematic review methodologies, ensuring the analytical expertise necessary to present these complex findings in a highly accessible and interpretable format (see Data synthesis, paragraph 8). If the reviewer would like any further specific detail, we would be happy to add this.